What are the recommended ceftriaxone and azithromycin dosing regimens for adults and children with complicated typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dosing for Complicated Typhoid Fever

For complicated typhoid fever, use ceftriaxone 80 mg/kg/day IV once daily (maximum 4 g/day) for 10-14 days, or azithromycin 20 mg/kg/day orally once daily (maximum 1 g/day) for 7 days, with ceftriaxone preferred for severe disease requiring parenteral therapy. 1

Ceftriaxone Dosing

Children

  • 80 mg/kg/day IV once daily for complicated typhoid fever 1
  • Maximum dose: 4 g/day
  • Duration: 5-7 days for uncomplicated cases 1, but extend to 10-14 days for complicated disease (severe illness, complications like intestinal perforation, shock, or altered mental status)
  • Administer over 60 minutes in neonates to reduce bilirubin encephalopathy risk 2
  • Administer over 30 minutes in older children 2

Adults

  • 2-4 g IV once daily for complicated typhoid
  • Duration: 10-14 days for complicated disease
  • No dose adjustment needed for renal or hepatic impairment 2

Azithromycin Dosing

Children

  • 20 mg/kg/day orally once daily (maximum 1 g/day) 1
  • Duration: 5-7 days 1
  • Can be used as second-line or when oral therapy is appropriate 1

Adults

  • 1 g orally once daily for 5-7 days
  • Alternative: 500 mg on day 1, then 250 mg daily for days 2-7 3

Clinical Decision Algorithm

Choose ceftriaxone when:

  • Patient has severe/complicated disease (high fever >39°C, altered mental status, shock, suspected perforation)
  • Patient cannot tolerate oral medications
  • Patient has known or suspected ceftriaxone-susceptible strain
  • Parenteral therapy is required

Choose azithromycin when:

  • Patient has uncomplicated disease and can take oral medications
  • Strain shows reduced fluoroquinolone susceptibility (nalidixic acid resistant) 4
  • Outpatient management is appropriate
  • Patient is from South Asia where fluoroquinolone resistance is common 5

Critical caveat: If the patient is from Pakistan, be aware of extensively drug-resistant (XDR) strains resistant to both ceftriaxone and fluoroquinolones 5. In this scenario, azithromycin remains the only reliable oral option, as no isolates have shown azithromycin resistance 5.

Important Considerations

For complicated typhoid, longer treatment duration (10-14 days) is essential compared to uncomplicated cases (5-7 days). Complicated disease includes:

  • Intestinal perforation or bleeding
  • Encephalopathy or altered mental status
  • Myocarditis
  • Shock or severe sepsis
  • Hepatic or splenic abscess

Combination therapy (azithromycin + cefixime) is being studied but not yet standard of care 6. Current evidence supports monotherapy with either agent.

Relapse rates: Azithromycin may have lower relapse rates than ceftriaxone (0% vs 17% in one pediatric study) 7, though ceftriaxone shows faster fever clearance 8.

Resistance patterns matter: The WHO guidelines 1 list ciprofloxacin as first-line, but this is outdated given widespread fluoroquinolone resistance in South Asia (>90% of isolates) 5. Ceftriaxone and azithromycin are now the practical first-line choices.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.